RNVU1-19

Across TCGA pan-cancer cohorts, RNVU1-19 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RNVU1-19 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RNVU1-19 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNVU1-19 expression acts as an unfavorable survival marker, although some lineages such as PAAD and DLBC show a favorable association.

KICH, PAAD, and LGG are the cancer types where RNVU1-19 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	III,IV	0.201	0.802	<.001	72	view →
PAAD	OS	Tertile	II,III,IV	0.540	0.351	.007	44	view →
LGG	DFS	Tertile	All	0.281	0.436	<.001	25	view →
CESC	OS	Quartile	IV	0.214	0.681	.006	24	view →
DLBC	DFS	Tertile	All	1.000	0.412	.008	21	view →
SKCM	DFS	Median	All	0.256	0.143	.001	16	view →
BLCA	DFS	Median	III,IV	0.606	0.497	.016	16	view →
ESCA	OS	Median	IV	0.698	0.222	.006	12	view →
OV	DFS	Quartile	IV	0.282	0.535	.017	12	view →
KIRC	DFS	Tertile	III,IV	0.759	0.528	.007	8	view →
BRCA	OS	Median	All	0.971	0.954	.015	8	view →
READ	OS	Tertile	II,III,IV	0.994	0.863	.019	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RNVU1-19–KICH (OS)

Open the KICH breakdown →